| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $156K | — |
| SG&A Expense | $5.4M | — |
| Operating Income | -$6.7M | — |
| Interest Expense | $59K | — |
| Pre-tax Income | -$6.5M | — |
| Net Income | -$6.5M | — |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $2.7M | — |
| Total Assets | $2.7M | — |
| Total Liabilities | $14.5M | — |
| Stockholders' Equity | -$11.8M | — |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | — |
| Investing Cash Flow | $114K | — |
| Financing Cash Flow | $5.0M | — |